Showing results (461-470 of 610) with videos related to

Sort By:
Pageof 61
American Journal of Obstetrics and Gynecology|March 7, 2017
Maternal stress and neonatal anthropometry: the NICHD Fetal Growth StudiesDeborah A Wing, Ana M Ortega-Villa, William A Grobman, et al.
American Journal of Clinical Oncology|September 17, 2016
Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized TrialKaren E Hoffman, Heath Skinner, Thomas J Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trialKaren E Hoffman, K Ranh Voong, Thomas J Pugh, et al.
British Journal of Cancer|July 16, 2019
Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trialZachary W Veitch, David W Cescon, Trisha Denny, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 8, 2014
The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencingTrevor J Pugh, Melissa A Kelly, Sivakumar Gowrisankar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2023
Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer centerAlan J Sosa, Howard D Thames, Jeremiah W Sanders, et al.
Molecular Cancer Research : MCR|September 24, 2021
Mutations in Noncoding Cis-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast CancerSamah El Ghamrasni, Rene Quevedo, James Hawley, et al.
International Journal of Radiation Oncology, Biology, Physics|December 13, 2017
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life OutcomesSteven J Frank, Thomas J Pugh, Pierre Blanchard, et al.
Cell Reports|November 1, 2018
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell CarcinomaChristina Karamboulas, Jeffrey P Bruce, Andrew J Hope, et al.
European Urology Oncology|August 8, 2020
Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)Megan Crumbaker, Sarennya Pathmanandavel, Andrew O Yam, et al.
Pageof 61